Author By adminPosted on December 22, 2025December 23, 2025超20亿美元！同宜医药全球首款Bi-XDC药物出海，探索前列腺癌治疗新边界同宜医药宣布已与 MultiValent Biotherapies, Inc.（以下简称“MultiValent”）就治疗前列腺癌的多肽类偶联药物 CBP-1018 达成独家许可协议。
Author By adminPosted on February 23, 2025February 23, 2025The U.S. FDA Grants Fast Track Designation to Coherent Biopharma’s CBP-1019Suzhou, China, February 21, 2025 — Coherent Biopharma (“Coherent”) announced that the U.S. Food and Drug Administration...
